
### [Orphanet:398940](http://www.orpha.net/ORDO/Orphanet_398940)
**Label:** Malignant non-epithelial tumor of ovary

**Subclasses:** [Orphanet:206484](http://www.orpha.net/ORDO/Orphanet_206484) (Gonadoblastoma), [Orphanet:35807](http://www.orpha.net/ORDO/Orphanet_35807) (Malignant germ cell tumor of ovary), 

**Corr. equiv. classes:** [OMIM:424500](http://purl.obolibrary.org/obo/OMIM_424500), [Orphanet:206484](http://www.orpha.net/ORDO/Orphanet_206484), [OMIM:603737](http://purl.obolibrary.org/obo/OMIM_603737), [Orphanet:35807](http://www.orpha.net/ORDO/Orphanet_35807), 

**Class expressions from DL-Learner:**

- [HP:0008703](http://purl.obolibrary.org/obo/HP_0008703) (Gonadal calcification) 62.50%
- [HP:0030348](http://purl.obolibrary.org/obo/HP_0030348) (Increased circulating androgen level) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0030347](http://purl.obolibrary.org/obo/HP_0030347) (Abnormal circulating androgen level) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0030088](http://purl.obolibrary.org/obo/HP_0030088) (Increased serum testosterone level) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0030087](http://purl.obolibrary.org/obo/HP_0030087) (Abnormal serum testosterone level) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0010766](http://purl.obolibrary.org/obo/HP_0010766) (Ectopic calcification) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0008730](http://purl.obolibrary.org/obo/HP_0008730) (Female external genitalia in individual with 46,XY karyotype) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0008723](http://purl.obolibrary.org/obo/HP_0008723) (Gonadal dysgenesis with female appearance, male) and [HP:0100621](http://purl.obolibrary.org/obo/HP_0100621) (Dysgerminoma) 62.50%
- [HP:0008723](http://purl.obolibrary.org/obo/HP_0008723) (Gonadal dysgenesis with female appearance, male) and [HP:0100620](http://purl.obolibrary.org/obo/HP_0100620) (Germinoma) 62.50%
- [HP:0008723](http://purl.obolibrary.org/obo/HP_0008723) (Gonadal dysgenesis with female appearance, male) and [HP:0100615](http://purl.obolibrary.org/obo/HP_0100615) (Ovarian neoplasm) 62.50%


